Why Are 21 Billionaires Moving Their Money ASAP?
One of the biggest stock market events in 25 years is rapidly unfolding... The economist who predicted the 2008 Financial Crisis says it will be: "The Biggest Crash of Our Lifetime." Starting November 19 it could cut the entire tech marketing by HALF.
About Bristol-Myers Squibb Co
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.
General
| Name | Bristol-Myers Squibb Co |
| Ticker | BMY |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 34,100 |
Highlights
| Analyst Target | 52.65 |
| Market Cap | 92,810,000,000 |
| PE Ratio | 15.39 |
| PEG Ratio | 2.26 |
| EBITDA | 19,217,000,448 |
Share Stats
| Shares Outstanding | 2,036,000,000 |
| Shares Float | 2,034,560,000 |
| Shares Short | 30,360,000 |
| Insider Holdings | 7% |
| Institution Holdings | 83.40% |
Highlights
| Analyst Target | 52.65 |
| Market Cap | 92,810,000,000 |
| PE Ratio | 15.39 |
| PEG Ratio | 2.26 |
| EBITDA | 19,217,000,448 |
Valuation
| Trailing PE | 15.35 |
| Forward PE | 7.58 |
| Price/Sales (Trailing 12 Mt.) | 1.93 |
| Price/Book (Most Recent Quarter) | 5.34 |
Dividend
Bristol-Myers Squibb Co pays out a dividend of $2.47 per share, with a dividend yield of 5.42%.
BMY's last dividend payment was made to shareholders on November 3, 2025.
They pay out 0.00% of their earnings out as a dividend.
Recent Dividends
| Nov 3, 2025 | $0.62 |
| Aug 1, 2025 | $0.62 |
| May 1, 2025 | $0.62 |
| Feb 3, 2025 | $0.62 |
| Nov 1, 2024 | $0.60 |
| Aug 1, 2024 | $0.60 |
| May 1, 2024 | $0.60 |
| Feb 1, 2024 | $0.60 |
Five 2026 vehicles you should absolutely wait for
Don’t buy that new car yet. If you can wait, you’ll have new 2026 model year options that aren’t out yet. Although some models barely change, others are completely redesigned and often get the latest features and improvements. Whether you’re interested in improved fuel economy, cutting-edge technology, or maybe just fresh and distinctive styling, there’s likely a car on the horizon that you’ll be interested in. To ensure you don’t miss out on the latest and greatest, the car experts at Edmunds highlight five vehicles you should consider waiting for.
Cathie Wood Warns Wall Street Is Missing AI's Biggest Opportunity In Healthcare, Calling It 'Sleeper' Investment Poised For Massive Returns
Cathie Wood, CEO of Ark Invest, believes healthcare is the most profound application of AI and Wall Street is overlooking its potential.
Is Big Pharma's Next Target Already in Play? - Ad
A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.
Warren Buffett's Berkshire Hathaway Bets Big On Consumer Brands Amid Economic Shifts
Warren Buffett and his successor Greg Abel have been directing Berkshire Hathaway towards consumer-centric investments throughout 2025.
Stability AI largely wins UK court battle against Getty Images over copyright and trademark
LONDON (AP) — Artificial intelligence company Stability AI mostly prevailed against Getty Images Tuesday in a British .
Gold Bars Are Pouring, but This Miner is Still Priced Like a Startup - Ad
You'd expect a gold miner with production, a full refinery, and big-name investors to be trading at a premium. But this one? It's still under $1
S&P Global Boosts Outlook As CEO Hails Exceptional Growth
S&P Global (NYSE: SPGI) shares surge after reporting strong Q3 results, beating expectations with adjusted earnings of $4.73 per share.
Ford's enormous F-150 becomes unlikely part of Japan's efforts to woo Trump
TOKYO (AP) — Japan's most iconic truck might be the tiny white transport vehicles that farmers use to lug gear on the narrow roads that link their rice fields.
The $43B Big Pharma Story is Starting Over-With a New Player - Ad
Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.
Why Are First Solar Shares Surging On Friday?
First Solar beats Q3 sales estimates and reports record module shipments. Analyst raises price target to $150 despite supply chain challenges.
Move Over, Musk—The World's Richest Woman Joined the $100B Club
Alice Walton, daughter of Walmart founder Sam Walton, is the richest woman in the world worth more than $100 billion.
Urgent Copper Stock With Strong Catalysts - Ad
Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.
President Trump returns to '60 Minutes' for first time after settling lawsuit against newsmagazine
President Donald Trump is returning to “60 Minutes” this weekend, his first appearance on the show since he this summer with CBS News over the newsmagazine's with Kamala Harris. Trump was interviewed by CBS' Norah O'Donnell Friday at Mar-a-Lago for the appearance, which will air this Sunday.
Instacart Powers Grubhub's Grocery Blitz Across America
Grubhub taps Instacart for nationwide grocery ordering, with Instacart fulfillment, pharmacy additions coming, and promos boosting adoption despite CART dip.
New Number One Copper Start Alert - Ad
EVs and AI devour copper. Supply cannot keep up. A Quebec discovery with high grade, infrastructure, and cheap power is funded to drill through the year. Catalysts are lining up. Institutions are circling. Move now while it is still early.
China May Have Made A Breakthrough With Solid State Batteries Offering 600-Mile+ Range, Here's What You Should Know
Chinese researchers' share breakthrough in EV battery technology with solid-state batteries offering 600+ mile range and weighing 220 lbs.
Meta Lures Gen Z Talent With Six-Figure Salaries Amid Shrinking Job Opportunities — Here's How Much It's Offering
Meta is reportedly offering hefty paychecks for entry-level software engineering roles, a move seen as a response to the challenging job market for recent graduates.
Central Banks Are Buying More Gold Than Ever-And This U.S. Miner Is Ready to Oblige - Ad
Central banks are rapidly increasing their gold reserves-now nearly 20% of global assets. With rising demand and geopolitical pressure, U.S. gold supply is becoming more strategic than ever.
Texas Instruments Stock Is Tumbling Today: Here's Why
Texas Instruments shares are trading lower on Wednesday after the company issued fourth-quarter earnings and revenue guidance below analyst estimates.
Eli Lilly's Oral Weight Loss Drug Shows Superiority Over Two Approved Drugs
Orforglipron meets key endpoints in Phase 3 trials, showing A1C reduction, weight loss, and cardiovascular benefits for type 2 diabetes.
From Ore to Gold Bars-This Nevada Mine Is Already Producing - Ad
Most juniors explore...Few actually produce. This one's already pouring gold thanks to infrastructure that would cost tens of millions to build today. With major land holdings and room to scale, it's one to watch.
OpenAI's ChatGPT To Allow Erotica For Adults: Not 'Moral Police Of The World,' Sam Altman Says
OpenAI will begin allowing erotica and adult-themed content on ChatGPT, marking a major shift in the company's content policy.
Donald Trump Faces 'No Kings Day' Protests As Millions March Nationwide, GOP Stays Silent Amid Authoritarianism Claims
Millions rallied nationwide against Trump, with top lawmakers supporting protests and condemning Trump's consolidation of power.
"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad
George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before November 18's bombshell.
MP Materials, USA Rare Earth, Energy Fuels Shares Are Moving Lower: What's Going On?
Share of rare earth stocks are trading lower Monday amid potential U.S.-China negotiations that could delay export controls.
2,000 mink released from Iowa farm in what trade group calls 'terrorist act'
One or more intruders broke into an Iowa mink farm and released 2,000 of the furbearing animals in what a trade group called a “terrorist act” under federal law.
A Tiny Biotech Just Posted 10× Stronger Cancer Results - Ad
Early studies show this breakthrough delivery platform would make cancer treatments safer and more powerful. Now, with Big Pharma watching closely, investors are starting to take notice of what could be the next major biotech story.
Kevin O'Leary Said His Mom's Secret 55-Year-Old Investment Portfolio Outperformed Most Hedge Funds—He Decided Then, 'That's How I'm Going To Invest'
Shark Tank's Kevin O'Leary revealed how his mother's disciplined, 55-year investment strategy of diversification and long-term thinking shaped his own approach to building and preserving wealth.
Trump Commutes Former Rep. George Santos' Seven-Year Prison Term: '... Has Been Horribly Mistreated'
President Donald Trump announced on Friday that he commuted the prison sentence of former congressman George Santos (R-N.Y.), ordering his immediate release.
Why Are 21 Billionaires Moving Their Money ASAP? - Ad
One of the biggest stock market events in 25 years is rapidly unfolding... The economist who predicted the 2008 Financial Crisis says it will be: "The Biggest Crash of Our Lifetime." Starting November 19 it could cut the entire tech marketing by HALF.
Jeff Bezos-Backed Anthropic Projects To Nearly Triple Revenues By 2026: Report
Anthropic, the artificial intelligence (AI) startup, backed by Alphabet's (NASDAQ: GOOGL) (NASDAQ: GOOG) Google and Amazon.com (NASDAQ: AMZN), is reportedly projecting to more than double and potentially nearly triple its annualized revenue run rate next year.
Trump's immigration crackdown weighs heavy on the US labor market
Maria worked cleaning schools in Florida for $13 an hour. Every two weeks, she’d get a $900 paycheck from her employer, a contractor. Not much — but enough to cover rent in the house that she and her 11-year-old son share with five families, plus electricity, a cellphone and groceries.
Is Big Pharma's Next Target Already in Play? - Ad
A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.
Why Is BTQ Technologies Stock Up Today?
Shares of BTQ Technologies Corp. (NASDAQ:BTQ) are rising Thursday after the company announced that it reached a significant technological milestone.
Dogecoin's $0.21 Problem: Why This Analyst Says Keep It On Your Radar
On Monday, social media influencer Ali Martinez, known popularly on X as Ali, drew the attention of the crypto community to an important resistance level for Dogecoin (CRYPTO: DOGE).
Gold Bars Are Pouring, but This Miner is Still Priced Like a Startup - Ad
You'd expect a gold miner with production, a full refinery, and big-name investors to be trading at a premium. But this one? It's still under $1
IonQ Shares Are Trading Lower Monday: What's Going On?
IonQ shares were trading higher Monday but have since reversed and began trading lower.
Chinese leader Xi Jinping outlines 5-year plan at closed-door Communist Party meeting
BEIJING (AP) — Chinese leader Xi Jinping delivered a speech Monday on the opening day of of the ruling Communist Party to approve a draft plan laying out its goals for the country over the next five years.
The $43B Big Pharma Story is Starting Over-With a New Player - Ad
Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.
Hims & Hers, Salesforce, Omeros, United Airlines, And Sea Ltd: Why These 5 Stocks Are On Investors' Radars Today
Major U.S. indices ended mixed on Wednesday, with the Dow Jones Industrial Average slipping 0.04% to 46,253.31.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.